Pricing Log in Create free account

Microbot Medical Inc. (MBOT) vs Nyxoah SA (NYXH)

Microbot Medical Inc. and Nyxoah SA are both Medical Devices companies. Nyxoah SA is the larger, with a market value of $82.6M against $71.9M — 1.1× the size. Nyxoah SA grew revenue faster over the last twelve months: 366.2% against −59.1%. Nyxoah SA has the higher net margin (−446.4% vs −3,955.2%) and the higher return on invested capital (−117.8% vs −850.5%). Across the 18 metrics below, Nyxoah SA leads on 11 and Microbot Medical Inc. on 7.

Valuation

Metric MBOT NYXH Medical Devices median
P/E n/m n/m 24.94
P/S 178.84 1.93 2.66
P/B 1.07 0.50 2.36
Price to free cash flow n/m n/m 28.12
EV/EBITDA n/m n/m 11.42
EV/Sales 21.51 0.15 2.76
Earnings yield (21.82%) (296.47%) (12.66%)
Free cash flow yield (24.27%) (178.51%) (7.18%)

Profitability

Metric MBOT NYXH Medical Devices median
Gross margin (166.30%) 60.16% 57.76%
Operating margin (4,480.03%) (391.25%) (14.84%)
Net margin (3,955.22%) (446.39%) (14.45%)
Free cash flow margin (4,340.11%) (344.99%) (5.70%)
Return on equity (32.91%) (124.41%) (10.56%)
Return on assets (30.68%) (68.23%) (17.26%)
Return on invested capital (850.51%) (117.82%) (5.22%)

Growth

Metric MBOT NYXH Medical Devices median
Revenue growth (TTM) (59.09%) 366.24% 10.41%
EPS growth (last fiscal year) 60.27% (36.22%) 28.17%
Revenue growth, 5-year CAGR 0.39% 170.14% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MBOT NYXH Medical Devices median
Debt to equity 0.00 0.72 0.04
Current ratio 18.56 2.38 2.67
Net debt to EBITDA 5.35 0.08 0.54

Dividend

Metric MBOT NYXH Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.38

Size

Metric MBOT NYXH Medical Devices median
Market cap 71.87m 82.59m 221.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack